Business ❯ Finance ❯ Investment
Institutional Investors Securities Non-Brokered Private Placement Securities Offering Common Shares Convertible Notes Biotechnology Venture Capital Fundraising Mining Financing Nebius Group Offering Warrants Non-brokered Private Placement Flow-Through Private Placement Non-Flow-Through Private Placement Panasonic Energy Business Operations Agreement Details Offering Terms Foremost Lithium Insiders Subscription Prices Units Issued Units Strategic Investment Sirona Biochem Corp. Proceeds Use of Proceeds Regulatory Requirements Convertible Security Funding Agreement Proceeds Use Non-Convertible Debentures Senior Unsecured Notes Mineral Development Valuation Funding Strategies Non-Brokered Financing Capital Raise Equity Sui Treasury Strategy Cryptocurrency Promoter Group Common Stock Corporate Financing Uranium Financing Healthcare Investments Tether Funding Crypto Treasury Model Nasdaq Inc. Promoter Holdings Digital Assets Travel Technology Biopharmaceuticals Tokenized Assets Winklevoss Capital Gilat Satellite Networks Tier 2 Bonds Publicly Listed Companies Qualified Institutional Placement Green Shoe Option Tier II Perpetual Debentures Debenture Units Capital Raising Common Share Purchase Warrants Forward-Looking Statements Investor Relations Talisker Resources Ltd. Share Offering Mining Finance URZ3 Energy Corp Flow-Through Shares
The rights exchange sets 2026 clinical launches under a split granting Kelun CR-001 in Greater China, leaving SKB105 to Crescent outside China.
